Time-of-day immunotherapy may represent a modifiable factor in cancer care, with earlier immune checkpoint inhibitor ...

Experts express concerns about unblinding effects in randomized trials ...

Coronary artery disease study shows similar mortality for CABG and PCI, but lower adverse events and revascularisation rates ...